4/A: Dong-A ST Co., Ltd. Corrects Share Price in Amended SEC Filing for NeuroBo Pharmaceuticals

Dong-A ST Co., Ltd. files an amended SEC Form 4 to correct a previously reported share price for a transaction involving NeuroBo Pharmaceuticals (NRBO) common stock.

Summary

• Dong-A ST Co., Ltd. filed an amendment to a Form 4 with the SEC.
• The amendment corrects a scrivener's error in the original Form 4 filed on June 25, 2024.
• The error concerned the price per share of NeuroBo Pharmaceuticals (NRBO) common stock acquired in a transaction on June 23, 2024.
• The original filing incorrectly reported the price as $3.13 per share.
• The corrected price per share is $3.93.
• Following the transaction, Dong-A ST Co., Ltd. beneficially owns 5,348,229 shares of NeuroBo Pharmaceuticals common stock.

Sentiment

Score: 7

Explanation: The document is a routine correction of a previous filing. While the initial error is a slight negative, the prompt correction is a positive. Overall, the sentiment is neutral to slightly positive.

Negatives

• The original Form 4 contained an error in the reported share price.

Management Comments

• Min Young Kim, Chief Executive Officer of Dong-A ST Co., Ltd., signed the amended Form 4/A.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and major shareholders, providing transparency to the market.

Stakeholder Impact

• The correction of the share price ensures accurate information is available to shareholders and potential investors of NeuroBo Pharmaceuticals (NRBO).

Key Dates